1. Home
  2. NSPR vs PGP Comparison

NSPR vs PGP Comparison

Compare NSPR & PGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • PGP
  • Stock Information
  • Founded
  • NSPR 2005
  • PGP 2003
  • Country
  • NSPR United States
  • PGP United States
  • Employees
  • NSPR N/A
  • PGP N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • PGP Finance Companies
  • Sector
  • NSPR Health Care
  • PGP Finance
  • Exchange
  • NSPR Nasdaq
  • PGP Nasdaq
  • Market Cap
  • NSPR 75.1M
  • PGP 82.7M
  • IPO Year
  • NSPR N/A
  • PGP N/A
  • Fundamental
  • Price
  • NSPR $2.44
  • PGP $8.06
  • Analyst Decision
  • NSPR Strong Buy
  • PGP
  • Analyst Count
  • NSPR 2
  • PGP 0
  • Target Price
  • NSPR $4.50
  • PGP N/A
  • AVG Volume (30 Days)
  • NSPR 44.5K
  • PGP 39.8K
  • Earning Date
  • NSPR 08-05-2025
  • PGP 01-01-0001
  • Dividend Yield
  • NSPR N/A
  • PGP 10.84%
  • EPS Growth
  • NSPR N/A
  • PGP N/A
  • EPS
  • NSPR N/A
  • PGP N/A
  • Revenue
  • NSPR $7,027,000.00
  • PGP N/A
  • Revenue This Year
  • NSPR $27.41
  • PGP N/A
  • Revenue Next Year
  • NSPR $127.08
  • PGP N/A
  • P/E Ratio
  • NSPR N/A
  • PGP N/A
  • Revenue Growth
  • NSPR 8.49
  • PGP N/A
  • 52 Week Low
  • NSPR $2.07
  • PGP $5.83
  • 52 Week High
  • NSPR $3.80
  • PGP $7.81
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 50.84
  • PGP 57.47
  • Support Level
  • NSPR $2.40
  • PGP $7.92
  • Resistance Level
  • NSPR $2.59
  • PGP $8.07
  • Average True Range (ATR)
  • NSPR 0.11
  • PGP 0.08
  • MACD
  • NSPR 0.00
  • PGP -0.01
  • Stochastic Oscillator
  • NSPR 57.50
  • PGP 60.87

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About PGP Pimco Global StocksPlus & Income Fund of Beneficial Interest

PIMCO Global Stocksplus & Income Fund is a closed-end management investment company. The objective of the fund is to seek a total return comprised of current income, current gains, and long-term capital appreciation. The fund invests a majority of the fund's net assets in a combination of securities and instruments that provide exposure to stocks and or produce income.

Share on Social Networks: